Hepatitis B trials in China

In China 104 Also abroad 192

104 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Research on Clinical Recovery and Maintenance Strategies for CHB
Where
Beijing
Age
18 years to 65 years
People
285
Run by
Beijing Municipal Administration of Hospitals
See details and how to joinNCT06803368
No phaseTaking people
Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
Where
Beijing
Age
18 years and over
People
2,000
Run by
Beijing Friendship Hospital
See details and how to joinNCT06779864
No phaseEnrolling by invitation
Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
Where
Beijing
Age
18 years to 65 years
People
180
Run by
Beijing Ditan Hospital
See details and how to joinNCT06777173
Early phase 1Not yet taking people in China
An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
Where
Shanghai
Age
18 years to 65 years
People
20
Run by
Epigenic Therapeutics, Inc
See details and how to joinNCT06745973
No phaseTaking people
Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.
Where
Chenzhou, Guangzhou, Hengyang
Age
18 years to 65 years
People
400
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT06746701
No phaseEnrolling by invitation
A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Where
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Guanzhou, Harbin, Hefei, Shanghai, Shenyang, Shenzhen, Taiyuan, Tianjin, Ürümqi, Wuhan, Xiamen, Xi'an, Xi’an, Yanji, Zhengzhou
Age
18 years and over
People
350
Run by
Xiamen Amoytop Biotech Co., Ltd.
See details and how to joinNCT06707922
No phaseTaking people
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
Where
Guangzhou
Age
18 years to 65 years
People
100
Run by
Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT02883647
No phaseTaking people
Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF
Where
Guangzhou
Age
12 years to 65 years
People
150
Run by
Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT03920618
No phaseTaking people
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
Where
Guangzhou
Age
18 years to 65 years
People
300
Run by
Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT04310787
No phaseTaking people
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
Where
Guangzhou
Age
18 years to 65 years
People
200
Run by
Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT04597164
No phaseTaking people
Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon
Where
Beijing
Age
18 years to 70 years
People
120
Run by
Minghui Li
See details and how to joinNCT06696664
Phase 1Not yet taking people in China
Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
Where
Hong Kong
Age
18 years to 65 years
People
36 worldwide
Run by
Epigenic Therapeutics, Inc
See details and how to joinNCT06661148
No phaseTaking people
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
Where
Shanghai
Age
18 years to 65 years
People
300
Run by
Huashan Hospital
See details and how to joinNCT06550622
No phaseTaking people
A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
Where
Beijing, Changchun, Chongqing, Nanjing, Wuhan
Age
18 years to 50 years
People
250
Run by
Tongji Hospital
See details and how to joinNCT06525909
Phase 4Taking people
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Where
Ningbo, Rui’an, Wenzhou, Yueqing
Age
18 years to 60 years
People
1,500
Run by
First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06368882
No phaseTaking people
Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
Where
Shanghai
Age
18 years to 65 years
People
2,016
Run by
Qing XIe
See details and how to joinNCT06323681
No phaseTaking people
Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
Where
Guangzhou
Age
18 years to 65 years
People
200
Run by
Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT04231565
No phaseTaking people
HBsAg Declined Patients Follow-up Study
Where
Guangzhou
Age
18 years to 65 years
People
100
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT05977283
No phaseTaking people
Hepatitis B Vaccination After Neonatal Surgery
Where
Chongqing
People
180
Run by
Children's Hospital of Chongqing Medical University
See details and how to joinNCT06023056
No phaseTaking people
Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients
Where
Guangzhou
Age
18 years to 65 years
People
60
Run by
Guangzhou 8th People's Hospital
See details and how to joinNCT05988879
No phaseNot yet taking people in China
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
Where
Fuzhou, Hefei, Jinan, Kunming, Nanjing, Shanghai, Taiyuan, Wuhan, Xi’an, Xuzhou
Age
18 years to 80 years
People
5,000
Run by
Wen-hong Zhang
See details and how to joinNCT05965388
No phaseTaking people
Real-world Study Optimizing Nucleotide-analogues
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guiyang, Ha’erbin, Haikou, Hangzhou, Hefei, Jinan, Kunming, Lanzhou, Meizhou, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Ürümqi, Wuhan, Xiamen, Xi’an, Xuzhou, Zhengzhou
Age
18 years to 80 years
People
20,000
Run by
Huashan Hospital
See details and how to joinNCT05937178
Early phase 1Taking people
Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B
Where
Hefei
Age
18 years to 60 years
People
1,084
Run by
Anhui Medical University
See details and how to joinNCT05922306
No phaseTaking people
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
Where
Shanghai
Age
18 years to 75 years
People
20,000
Run by
Ruijin Hospital
See details and how to joinNCT05870969
No phaseTaking people
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
Where
Nanjing
Age
18 years and over
People
1,000
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT05766449